MAPKAP kinases MK2 and MK3 in inflammation: Complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin

被引:85
|
作者
Ronkina, Natalia [1 ]
Menon, Manoj B. [1 ]
Schwermann, Jessica [1 ]
Tiedje, Christopher [1 ]
Hitti, Edward [1 ]
Kotlyarov, Alexey [1 ]
Gaestel, Matthias [1 ]
机构
[1] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany
关键词
Protein kinase; mRNA stability; mRNA translation; lipopolysaccharide; transcription; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; ALPHA-MESSENGER-RNA; AU-RICH ELEMENTS; NF-KAPPA-B; BENZOTHIOPHENE INHIBITORS; PROTEIN-KINASE-2; MK-2; P38; MAPK; MITOGEN; STABILITY;
D O I
10.1016/j.bcp.2010.06.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Downstream of mitogen-activated protein kinases (MAPKs), three structurally related MAPK-activated protein kinases (MAPKAPKs or MKs) - MK2, MK3 and MK5 - signal to diverse cellular targets. Although there is no known common function for all three MKs, MK2 and MK3 are mainly involved in regulation of gene expression at the post-transcriptional level and are implicated in inflammation and cancer. MK2 and MK3 are phosphorylated and activated by p38(MAPK alpha,beta) and, in turn phosphorylate various substrates involved in diverse cellular processes. In addition to forwarding of the p38-signal by MK2/3, protein complex formation between MK2/3 and p38 mutually stabilizes these enzymes and affects p38(MAPK) signaling in general. Among the substrates of MK2/3, there are mRNA-AU-rich-element (ARE)-binding proteins, such as tristetraprolin (UP) and hnRNP As, which regulate mRNA stability and translation in a phosphorylation-dependent manner. Phosphorylation by MK2 stabilizes TIT, releases ARE-containing mRNAs, such as TNF-mRNA, from default translational repression and inhibits their nucleolytic degradation. Here we demonstrate that MK2/3 also contribute to the de novo synthesis of UP. Whether this contribution proceeds via transcription factors directly targeted by MK2/3 or via chromatin remodeling by the reported binding of MK2/3 to the polycomb repressive complex is still open. A model is proposed, which demonstrates how this new function of transcriptional activation of UP by MK2/3 cooperates with the role of MK2/3 in post-transcriptional gene expression to limit the inflammatory response. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:1915 / 1920
页数:6
相关论文
共 50 条
  • [41] Regulation of Postoperative Ileus by Lentivirus-Mediated HuR RNA Interference via the p38/MK2 Signaling Pathway
    Ye Dao Xiong
    Lu Xing Rong
    Chi Pan
    Journal of Gastrointestinal Surgery, 2017, 21 : 389 - 397
  • [42] Applications of 3D-QSAR and structure-based pharmacophore modeling, virtual screening, ADMET, and molecular docking of putative MAPKAP-K2 (MK2) inhibitors
    Wang, Tai-Jin
    Zhou, Lu
    Fei, Jia
    Li, Zi-Cheng
    He, Lu-fen
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (10) : 4818 - 4829
  • [43] MK2/3 Are Pivotal for IL-33-Induced and Mast Cell-Dependent Leukocyte Recruitment and the Resulting Skin Inflammation
    Drube, Sebastian
    Kraft, Florian
    Dudeck, Jan
    Mueller, Anna-Lena
    Weber, Franziska
    Goepfert, Christiane
    Meininger, Isabel
    Beyer, Mandy
    Irmler, Ingo
    Haefner, Norman
    Schuetz, Dagmar
    Stumm, Ralf
    Yakovleva, Tatiana
    Gaeste, Matthias
    Dudeck, Anne
    Kamradt, Thomas
    JOURNAL OF IMMUNOLOGY, 2016, 197 (09): : 3662 - 3668
  • [44] Monitoring Native p38α:MK2/3 Complexes via Trans Delivery of an ATP Acyl Phosphate Probe
    Okerberg, Eric S.
    Brown, Heidi E.
    Minimo, Lauro
    Alemayehu, Senait
    Rosenblum, Jonathan
    Patricelli, Matt
    Nomanbhoy, Tyzoon
    Kozarich, John W.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (12) : 4664 - 4669
  • [45] Applications of 3D-QSAR and structure-based pharmacophore modeling, virtual screening, ADMET, and molecular docking of putative MAPKAP-K2 (MK2) inhibitors
    Tai-Jin Wang
    Lu Zhou
    Jia Fei
    Zi-Cheng Li
    Lu-fen He
    Medicinal Chemistry Research, 2013, 22 : 4818 - 4829
  • [46] MMI-0100, a Novel MAPKAP Kinase II (MK2) Inhibitor, Delivered Via Inhalation, Displays an Excellent Safety and Tolerability Profile in Three Phase 1 Clinical Trials
    Luber, A.
    Peterson, C.
    Panitch, A.
    Wetering, J.
    Hoogdalem, E.
    Nicholson, G.
    Leaker, B.
    Lander, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [47] Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-α involves activation of the MKK6/p38MAPK/MK2 cascade
    Ehlting, Christian
    Lai, Wi S.
    Schaper, Fred
    Brenndoerfer, Erwin D.
    Matthes, Raphaela-Jessica
    Heinrich, Peter C.
    Ludwig, Stephan
    Blackshear, Perry J.
    Gaestel, Matthias
    Haeussinger, Dieter
    Bode, Johannes G.
    JOURNAL OF IMMUNOLOGY, 2007, 178 (05): : 2813 - 2826
  • [48] The MK2/HuR signaling pathway regulates TNF-α-induced ICAM-1 expression by promoting the stabilization of ICAM-1 mRNA
    Ting Wu
    Jia-Xin Shi
    Shen Geng
    Wei Zhou
    Yi Shi
    Xin Su
    BMC Pulmonary Medicine, 16
  • [49] The MK2/HuR signaling pathway regulates TNF-α-induced ICAM-1 expression by promoting the stabilization of ICAM-1 mRNA
    Wu, Ting
    Shi, Jia-Xin
    Geng, Shen
    Zhou, Wei
    Shi, Yi
    Su, Xin
    BMC PULMONARY MEDICINE, 2016, 16
  • [50] Regulation of CCR4-NOT complex deadenylase activity and cellular responses by MK2-dependent phosphorylation of CNOT2
    Suzuki, Toru
    Hoshina, Miyuki
    Nishijima, Saori
    Hoshina, Naosuke
    Kikuguchi, Chisato
    Tomohiro, Takumi
    Fukao, Akira
    Fujiwara, Toshinobu
    Yamamoto, Tadashi
    RNA BIOLOGY, 2022, 19 (01) : 234 - 246